| Product Code: ETC13149431 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Neurovascular Coiling Assist Devices Market was valued at USD 0.55 Billion in 2024 and is expected to reach USD 0.78 Billion by 2031, growing at a compound annual growth rate of 5.60% during the forecast period (2025-2031).
The Global Neurovascular Coiling Assist Devices Market is experiencing steady growth, driven by an increasing incidence of aneurysms and demand for minimally invasive procedures. These devices aid in the precise placement of coils during endovascular coiling procedures, enhancing successful treatment outcomes. Key market players are investing in advanced technologies to improve device efficacy and patient safety. North America dominates the market due to high healthcare spending and advanced healthcare infrastructure. However, the Asia-Pacific region is expected to witness significant growth due to rising healthcare investments and a growing patient population. Technological advancements, coupled with strategic collaborations and product launches, are key strategies adopted by market players to maintain a competitive edge in this rapidly evolving market.
The Global Neurovascular Coiling Assist Devices Market is experiencing a growing demand due to the increasing incidence of cerebrovascular diseases such as aneurysms and strokes. Technological advancements in coiling assist devices, such as the development of detachable coils and flow diverters, are driving market growth. Additionally, the rising adoption of minimally invasive procedures and the expanding elderly population are contributing to the market expansion. Opportunities in the market include the potential for further innovation in device design and materials, as well as the untapped potential in emerging economies with improving healthcare infrastructure. Market players are focusing on strategic collaborations and product launches to capitalize on these trends and opportunities in the neurovascular coiling assist devices market.
The Global Neurovascular Coiling Assist Devices Market faces challenges such as limited awareness among healthcare professionals about the benefits of coiling assist devices, leading to slower adoption rates. Additionally, the high cost associated with these devices can be a barrier for healthcare facilities, especially in developing regions. Stringent regulatory requirements and the need for specialized training for healthcare providers to effectively use these devices also pose challenges in the market. Moreover, the competitive landscape with the presence of established players offering a variety of coiling assist devices further intensifies the market competition, making it challenging for new entrants to penetrate the market and gain significant market share. Overall, addressing these challenges will be crucial for the growth and development of the Global Neurovascular Coiling Assist Devices Market.
The Global Neurovascular Coiling Assist Devices Market is primarily driven by the increasing prevalence of cerebral aneurysms and ischemic strokes, which has led to a growing demand for minimally invasive treatments such as neurovascular coiling procedures. Technological advancements in coiling assist devices, such as the development of detachable coils and bioactive coatings, are also fueling market growth by improving the efficacy and safety of procedures. Additionally, rising awareness among healthcare professionals and patients about the benefits of neurovascular coiling in reducing the risk of recurrent aneurysms and minimizing complications further contribute to market expansion. Moreover, the growing geriatric population, who are more susceptible to neurovascular disorders, is expected to drive the demand for coiling assist devices in the coming years.
Government policies related to the Global Neurovascular Coiling Assist Devices Market primarily focus on ensuring the safety, efficacy, and quality of these medical devices. Regulatory bodies such as the Food and Drug Administration (FDA) in the United States and the European Medicines Agency (EMA) in the European Union have established stringent approval processes to assess the performance and safety of neurovascular coiling assist devices before they can be marketed. These policies aim to protect patient health and promote innovation in the industry while ensuring compliance with legal and ethical standards. Additionally, reimbursement policies set by government healthcare systems play a crucial role in determining the market access and adoption of these devices, impacting healthcare providers` willingness to invest in these technologies for patient care.
The Global Neurovascular Coiling Assist Devices Market is anticipated to witness significant growth in the coming years due to the increasing prevalence of neurovascular diseases, such as aneurysms and strokes. Technological advancements in coiling procedures and the rising adoption of minimally invasive techniques are driving market expansion. Moreover, the growing geriatric population and the rising demand for innovative treatment options are expected to further propel market growth. Additionally, the increasing investments in healthcare infrastructure and the availability of reimbursement policies for neurovascular procedures are likely to contribute to the market`s positive outlook. However, challenges such as high costs associated with coiling assist devices and regulatory hurdles may hinder market growth to some extent. Overall, the Global Neurovascular Coiling Assist Devices Market is poised for steady growth in the foreseeable future.
In the global neurovascular coiling assist devices market, North America holds a significant share due to the presence of well-established healthcare infrastructure and increasing prevalence of neurovascular diseases. Europe follows closely behind with a growing aging population and rising awareness about minimally invasive procedures. Asia Pacific is expected to witness the fastest growth, driven by improving healthcare facilities, increasing healthcare expenditure, and rising cases of neurological disorders in countries like China and India. The Middle East and Africa region is also anticipated to show steady growth as healthcare investments increase. Latin America is experiencing a rise in demand for neurovascular coiling assist devices, attributed to improving healthcare access and growing awareness about advanced treatment options for neurovascular conditions.
Global Neurovascular Coiling Assist Devices Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Neurovascular Coiling Assist Devices Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Neurovascular Coiling Assist Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Global Neurovascular Coiling Assist Devices Market - Industry Life Cycle |
3.4 Global Neurovascular Coiling Assist Devices Market - Porter's Five Forces |
3.5 Global Neurovascular Coiling Assist Devices Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Neurovascular Coiling Assist Devices Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Global Neurovascular Coiling Assist Devices Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Global Neurovascular Coiling Assist Devices Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Global Neurovascular Coiling Assist Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Neurovascular Coiling Assist Devices Market Trends |
6 Global Neurovascular Coiling Assist Devices Market, 2021 - 2031 |
6.1 Global Neurovascular Coiling Assist Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Neurovascular Coiling Assist Devices Market, Revenues & Volume, By Coil Assist Stents, 2021 - 2031 |
6.1.3 Global Neurovascular Coiling Assist Devices Market, Revenues & Volume, By Coil Assist Balloons, 2021 - 2031 |
6.2 Global Neurovascular Coiling Assist Devices Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Neurovascular Coiling Assist Devices Market, Revenues & Volume, By Aneurysms, 2021 - 2031 |
6.2.3 Global Neurovascular Coiling Assist Devices Market, Revenues & Volume, By Arteriovascular Malformations (AVMs), 2021 - 2031 |
6.2.4 Global Neurovascular Coiling Assist Devices Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Global Neurovascular Coiling Assist Devices Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Neurovascular Coiling Assist Devices Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 Global Neurovascular Coiling Assist Devices Market, Revenues & Volume, By Ambulatory Surgical Centers, 2021 - 2031 |
6.3.4 Global Neurovascular Coiling Assist Devices Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Neurovascular Coiling Assist Devices Market, Overview & Analysis |
7.1 North America Neurovascular Coiling Assist Devices Market Revenues & Volume, 2021 - 2031 |
7.2 North America Neurovascular Coiling Assist Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Neurovascular Coiling Assist Devices Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Neurovascular Coiling Assist Devices Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Neurovascular Coiling Assist Devices Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Neurovascular Coiling Assist Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.4 North America Neurovascular Coiling Assist Devices Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5 North America Neurovascular Coiling Assist Devices Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Latin America (LATAM) Neurovascular Coiling Assist Devices Market, Overview & Analysis |
8.1 Latin America (LATAM) Neurovascular Coiling Assist Devices Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Neurovascular Coiling Assist Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Neurovascular Coiling Assist Devices Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Neurovascular Coiling Assist Devices Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Neurovascular Coiling Assist Devices Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Neurovascular Coiling Assist Devices Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Neurovascular Coiling Assist Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
8.4 Latin America (LATAM) Neurovascular Coiling Assist Devices Market, Revenues & Volume, By Application, 2021 - 2031 |
8.5 Latin America (LATAM) Neurovascular Coiling Assist Devices Market, Revenues & Volume, By End User, 2021 - 2031 |
9 Asia Neurovascular Coiling Assist Devices Market, Overview & Analysis |
9.1 Asia Neurovascular Coiling Assist Devices Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Neurovascular Coiling Assist Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Neurovascular Coiling Assist Devices Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Neurovascular Coiling Assist Devices Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Neurovascular Coiling Assist Devices Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Neurovascular Coiling Assist Devices Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Neurovascular Coiling Assist Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
9.4 Asia Neurovascular Coiling Assist Devices Market, Revenues & Volume, By Application, 2021 - 2031 |
9.5 Asia Neurovascular Coiling Assist Devices Market, Revenues & Volume, By End User, 2021 - 2031 |
10 Africa Neurovascular Coiling Assist Devices Market, Overview & Analysis |
10.1 Africa Neurovascular Coiling Assist Devices Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Neurovascular Coiling Assist Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Neurovascular Coiling Assist Devices Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Neurovascular Coiling Assist Devices Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Neurovascular Coiling Assist Devices Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Neurovascular Coiling Assist Devices Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Neurovascular Coiling Assist Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
10.4 Africa Neurovascular Coiling Assist Devices Market, Revenues & Volume, By Application, 2021 - 2031 |
10.5 Africa Neurovascular Coiling Assist Devices Market, Revenues & Volume, By End User, 2021 - 2031 |
11 Europe Neurovascular Coiling Assist Devices Market, Overview & Analysis |
11.1 Europe Neurovascular Coiling Assist Devices Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Neurovascular Coiling Assist Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Neurovascular Coiling Assist Devices Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Neurovascular Coiling Assist Devices Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Neurovascular Coiling Assist Devices Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Neurovascular Coiling Assist Devices Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Neurovascular Coiling Assist Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
11.4 Europe Neurovascular Coiling Assist Devices Market, Revenues & Volume, By Application, 2021 - 2031 |
11.5 Europe Neurovascular Coiling Assist Devices Market, Revenues & Volume, By End User, 2021 - 2031 |
12 Middle East Neurovascular Coiling Assist Devices Market, Overview & Analysis |
12.1 Middle East Neurovascular Coiling Assist Devices Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Neurovascular Coiling Assist Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Neurovascular Coiling Assist Devices Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Neurovascular Coiling Assist Devices Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Neurovascular Coiling Assist Devices Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Neurovascular Coiling Assist Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
12.4 Middle East Neurovascular Coiling Assist Devices Market, Revenues & Volume, By Application, 2021 - 2031 |
12.5 Middle East Neurovascular Coiling Assist Devices Market, Revenues & Volume, By End User, 2021 - 2031 |
13 Global Neurovascular Coiling Assist Devices Market Key Performance Indicators |
14 Global Neurovascular Coiling Assist Devices Market - Export/Import By Countries Assessment |
15 Global Neurovascular Coiling Assist Devices Market - Opportunity Assessment |
15.1 Global Neurovascular Coiling Assist Devices Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Neurovascular Coiling Assist Devices Market Opportunity Assessment, By Product Type, 2021 & 2031F |
15.3 Global Neurovascular Coiling Assist Devices Market Opportunity Assessment, By Application, 2021 & 2031F |
15.4 Global Neurovascular Coiling Assist Devices Market Opportunity Assessment, By End User, 2021 & 2031F |
16 Global Neurovascular Coiling Assist Devices Market - Competitive Landscape |
16.1 Global Neurovascular Coiling Assist Devices Market Revenue Share, By Companies, 2024 |
16.2 Global Neurovascular Coiling Assist Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here